| Dr Salena Blackburn Potter, PHD, MFT | |
|
34 N Main St Ste 102, Arab, AL 35016-1240 | |
| (256) 541-2385 | |
| Not Available |
| Full Name | Dr Salena Blackburn Potter |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 34 N Main St Ste 102, Arab, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295226876 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | A177 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Salena Blackburn Potter, PHD, MFT 236 8th Ave Ne, Arab, AL 35016-1006 Ph: (256) 682-0500 | Dr Salena Blackburn Potter, PHD, MFT 34 N Main St Ste 102, Arab, AL 35016-1240 Ph: (256) 541-2385 |
News Archive
Pediatric laryngotracheal stenosis (LTS), a narrowing of the airway in children, is a complex medical condition. While it can be something a child is born with or caused by injury, the condition can result in a life-threatening emergency if untreated.
The Chamber's President and CEO Thomas Donohue vowed first and foremost to fight against the overhaul's employer mandate, but noted that in other cases the organization will work to fix flaws rather than repeal the measure.
BD Diagnostics, a segment of BD, a leading global medical technology company, today introduced two new erythrocyte sedimentation rate instruments in Europe that standardise analysis for more accurate, timely results and an efficient workflow in comparison to a manual Westergren method. This next generation of BD ESR instruments results in improved patient care in the laboratory or point of care setting.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today reported publication of a preclinical study in the current on-line edition of the journal Endocrinology showing that human growth hormone (hGH) linked to PROLOR's carboxyl terminal peptide (CTP) technology has significantly increased half-life and bioactivity compared to commercially available hGH. The publication, which is authored by PROLOR researchers, will also be included in the September print edition of Endocrinology.
The structure of the chaperonin complex of the bacteria Thermus thermophilus reveals clues about how the important molecule may do its job of folding new or damaged proteins within cells.
› Verified 7 days ago